- CH₣4.26bn
- CH₣4.50bn
- CH₣3.28bn
- 93
- 43
- 95
- 93
2019 December 31st | R2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,729 | 2,968 | 3,155 | 3,180 | 3,282 |
Cost of Revenue | |||||
Gross Profit | 1,121 | 873 | 947 | 989 | 1,101 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 3,488 | 2,835 | 2,934 | 3,069 | 2,952 |
Operating Profit | 241 | 133 | 222 | 111 | 330 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 213 | 111 | 198 | 107 | 304 |
Provision for Income Taxes | |||||
Net Income After Taxes | 158 | 71.5 | 141 | 28 | 231 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 154 | 83.5 | 1,417 | 28.6 | 229 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 154 | 83.6 | 1,417 | 28.6 | 229 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.94 | 3.37 | 4.5 | 4.81 | 7.28 |
Dividends per Share |